Open AccessThe Addition of Salmeterol 50 µg Bid to Anticholinergenic Treatment in Patients with COPD: A Randomized Placebo Controlled Trial
Author(s) -
Kenneth R. Chapman,
Peter Arvidsson,
AG Chuchalin,
DP Dhillon,
P Faurschou,
Roger Goldstein,
AF Kuipers
Publication year - 2002
Publication title -
canadian respiratory journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.675
H-Index - 53
eISSN - 1916-7245
pISSN - 1198-2241
DOI - 10.1155/2002/493296
Subject(s) - salmeterol , medicine , copd , placebo , anticholinergic , bronchodilator , randomized controlled trial , anesthesia , asthma , alternative medicine , pathology
In the past, the role of long-acting beta(2-) agonists in chronic obstructive pulmonary disease (COPD) relative to other agents has been unclear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom